RN Mobile Menu

Search form




Anca D. Askanase, M.D., MPH

LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.

Richard Alan Furie, M.D.

Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.

Childhood to adult (©NStudio/Shutterstock.com)

A longitudinal study of adults with childhood-onset lupus shows that disease damage accrues over the entire disease course.

(Systemic Lupus Erythematosus  ©farland80/Shutterstock.com)

For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.


There are few tests to accurately assess the degree and effects of lupus in children, but Ped-ANAM proves to be a promising option.

Lupus (©Designer491/Shutterstock.com)

Lupus patients who receive healthcare at more than one location face a greater risk of infection and comorbidities, research shows.

(Blisters ©komkritPreechachanwat/Shutterstock.com)

Researchers have made an important discovery that may lead to new treatment for patients with bullous pemphigoid, a chronic autoimmune skin disease causing blisters.


Subscribe to Lupus on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.